CNSP
CNS Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.73M
P/E Ratio
—
EPS
$-34.93
Beta
0.49
52W High
$16.56
52W Low
$2.06
50-Day MA
$3.47
200-Day MA
$6.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About CNS Pharmaceuticals Inc
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-15.98M |
| Operating Margin | 0.00% |
| Return on Equity | -296.30% |
| Return on Assets | -115.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $17.25 |
| Price-to-Book | 0.39 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 811,450 |
| Float | 714,980 |
| % Insiders | 0.12% |
| % Institutions | 19.03% |
Historical Volatility
HV 10-Day
68.27%
HV 20-Day
101.01%
HV 30-Day
92.06%
HV 60-Day
89.53%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/10/2026